IL1B and cryopyrin-associated periodic syndrome: The β‐sulfonyl nitrile compound OLT1177 also was shown to inhibit NLRP3‐mediated IL‐1β release from stimulated PBMCs of CAPS patients and primary human neutrophils (Figure 3).130